Cheryl Leong

Dr. Cheryl Leong

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CLCheryl Leong
Cheryl Leong
JCJoel Wai Kit Chan
Joel Wai Kit Chan
SLShi Mun Lee
Shi Mun Lee
YLYuen In Lam
Yuen In Lam
JGJoleen P. Z. Goh
Joleen P. Z. Goh
TDThomas L. Dawson
Thomas L. Dawson
Malassezia spp. are emerging fungal pathogens causing opportunistic skin and severe systemic infection. Nosocomial outbreaks are associated with azole resistance, and understanding of the underlying mechanisms is limited to knowledge of other fungal species.

21 November 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CLCheryl Leong
Cheryl Leong
SLSung Chan Lee
Sung Chan Lee
JOJiyeon Ock
Jiyeon Ock
XLXin Li
Xin Li
PSPeter See
Peter See
YCYoung-Tae Chang
Young-Tae Chang
Small molecule fluorescent probes offer significant advantages over conventional antibody and fluorescent protein labeling techniques. Here we present CDr10a and CDr10b, dyes that label live microglia specifically. They may be applied to the isolation and imaging of live microglia when investigating their role in neuroinflammatory diseases.

21 October 2020 in Mycoses
Verified
Journal Article
Closed access
PDF file
RCRiccardo Curatolo
Riccardo Curatolo
NJNada Juricevic
Nada Juricevic
CLCheryl Leong
Cheryl Leong
PBPhilipp P. Bosshard
Philipp P. Bosshard

1 November 2013 in Stem Cell Research
Verified
Journal Article
Closed access
CLCheryl Leong
Cheryl Leong
DZDuanting Zhai
Duanting Zhai
BKBeomsue Kim
Beomsue Kim
SYSeong-Wook Yun
Seong-Wook Yun
YCYoung-Tae Chang
Young-Tae Chang

9 March 2019 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
CLCheryl Leong
Cheryl Leong
BSBettina Schmid
Bettina Schmid
ABAntonino Buttafuoco
Antonino Buttafuoco
MGMartin Glatz
Martin Glatz
PBPhilipp P. Bosshard
Philipp P. Bosshard

3 June 2025 in Microbiology Spectrum
Verified
Journal Article
Open access
CLCheryl Leong
Cheryl Leong
WCWisely Chua
Wisely Chua
CCCheng-Shoong Chong
Cheng-Shoong Chong
SLShi Mun Lee
Shi Mun Lee
SMSebastian Maurer-Stroh
Sebastian Maurer-Stroh
TDThomas L. Dawson
Thomas L. Dawson
Malassezia are commensal lipid-dependent yeasts and opportunistic pathogens that cause superficial mycoses and systemic infection. Azole antifungals target cell wall ergosterol synthesis and are the first line of antifungal treatment. ERG11 gene mutations and overexpression are major mechanisms conferring azole resistance and resulting in antifungal therapy failure. Malassezia restricta is found ubiquitously on healthy and diseased skin, with azole-resistant isolates described. Malassezia arunalokei is a relatively new, closely related common skin species. Ketoconazole and itraconazole were the most effective at inhibiting both species. Isolates of M. restricta and M. arunalokei from healthy skin of Singapore subjects were cultured, evaluated, and generally susceptible to common over-the-counter azoles, including clotrimazole, except for select less-susceptible strains. Some less-susceptible strains have novel or reported non-synonymous mutations in the ERG11 gene, such as R88C. The QK178RQ ERG11 sequence variation was observed to be associated with differences in M. restricta and M. arunalokei as independent species. In the absence of identified ERG11 mutations, strains with elevated MICs were observed to have elevated ERG11 expression and drug efflux pump expression/activity. We conclude that antifungal susceptibility is determined by a combination of intrinsic (e.g., mutations, gene expression, efflux pump activity) and extrinsic (e.g., skin condition, prior antifungal exposure) factors and that the skin microbiome serves as a reference for the emergence of new mutations and strain phenotypes. IMPORTANCE: Malassezia over colonization is associated with conditions such as dandruff and seborrheic dermatitis, which give rise to unpleasant itching and swelling on the skin. Azole antifungals such as ketoconazole, clotrimazole, and miconazole are the primary treatments of choice available as over-the-counter creams or shampoos. However, the emergence of antifungal resistance leads to a loss of treatment efficacy and persistent fungal infection. To understand the mechanisms underlying antifungal resistance, we profiled the susceptibility profiles of commensal Malassezia isolates from the skin and identified novel ERG11 mutations. Our results indicate that antifungal susceptibility is determined by a combination of factors (mutations, efflux pump activity, gene expression, copy number) and suggest that the healthy skin microbiome serves as a reference for the emergence of new mutations and strain phenotypes.